Article 1 to 2 out of 2 concerning 4AZA Bioscience NV
elbion Merges With 4AZA to Form European Drug Discovery and Development Company(12/08/2006) elbion AG announced it has merged with 4AZA Bioscience NV, Belgium, to form a European company for discovery and development of drugs for CNS and immunological diseases. The combined company, to be called elbion NV ("elbion"), will be headquartered ...
4AZA Bioscience announces research collaboration with Gilead(12/02/2005) Companies to Pursue Early-Stage Compounds for the Treatment of Hepatitis C 4AZA Bioscience NV announced that the company has entered into a licensing agreement with Gilead Sciences to research and develop compounds for the potential treatment of hepatitis C virus (HCV) infection, a therapeutic area representing a ...
Top
